CEB-01 by Cebiotex for Leiomyosarcoma: Likelihood of Approval

CEB-01 is under clinical development by Cebiotex and currently in Phase I for Leiomyosarcoma.

Doc Travels for Abortion Training; Families Wrongly Separated; Jail Opioid Success

Welcome to the latest edition of Investigative Roundup, highlighting some of the best investigative reporting on healthcare each week. Doc Travels for Abortion Training Politico

September 12, 2024

Opioid prescribing limits may not worsen patient experience after common surgeries

Worries that surgery patients would have a tougher recovery if their doctors had to abide by a five-day limit on opioid pain medication prescriptions didn’t

October 13, 2023

Young Black and Hispanic women with multiple sclerosis fare worse than white women

While recent therapies have the potential to stall or delay the progression of multiple sclerosis, a new study shows that young Black and Hispanic women

January 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.